Spruce Biosciences Inc (NASDAQ: SPRB) kicked off on Monday, down -3.97% from the previous trading day, before settling in for the closing price of $0.37. Over the past 52 weeks, SPRB has traded in a range of $0.36-$5.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 24.68%. With a float of $28.49 million, this company’s outstanding shares have now reached $41.30 million.
Considering the fact that the conglomerate employs 29 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -14.36%, operating margin of -608.94%, and the pretax margin is -555.23%.
Spruce Biosciences Inc (SPRB) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Spruce Biosciences Inc is 31.03%, while institutional ownership is 22.15%. The most recent insider transaction that took place on Mar 21 ’24, was worth 350,951. In this transaction 10% Owner of this company sold 465,021 shares at a rate of $0.75, taking the stock ownership to the 2,550,000 shares. Before that another transaction happened on Mar 18 ’24, when Company’s 10% Owner sold 842,020 for $0.77, making the entire transaction worth $647,008. This insider now owns 3,968,000 shares in total.
Spruce Biosciences Inc (SPRB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.68% per share during the next fiscal year.
Spruce Biosciences Inc (NASDAQ: SPRB) Trading Performance Indicators
Take a look at Spruce Biosciences Inc’s (SPRB) current performance indicators. Last quarter, stock had a quick ratio of 5.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Spruce Biosciences Inc (SPRB)
Compared to the last year’s volume of 0.94 million, its volume of 1.2 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 10.23%. Additionally, its Average True Range was 0.03.
During the past 100 days, Spruce Biosciences Inc’s (SPRB) raw stochastic average was set at 4.96%, which indicates a significant decrease from 12.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.82% in the past 14 days, which was higher than the 66.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4710, while its 200-day Moving Average is $0.5592. Nevertheless, the first resistance level for the watch stands at $0.3698 in the near term. At $0.3844, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3982. If the price goes on to break the first support level at $0.3414, it is likely to go to the next support level at $0.3276. Now, if the price goes above the second support level, the third support stands at $0.3130.
Spruce Biosciences Inc (NASDAQ: SPRB) Key Stats
The company with the Market Capitalisation of 14.67 million has total of 41,303K Shares Outstanding. Its annual sales at the moment are 10,090 K in contrast with the sum of -47,920 K annual income. Company’s last quarter sales were recorded 600 K and last quarter income was -8,670 K.
